EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent

Symbat Zhumakova iD, Aliya Tokusheva, Tolganay Zharkynbek iD, Marina Balabekova, Sulev Koks, Tulegen Seilkhanov iD, Valery Dembitsky iD, Alexey Zazybin, Murat Aydemir, Ulan Kemelbekov iD, Gulgul Kairanbayeva iD, Valentina Yu iD

Molecules · 30.10.2024 · 29 (21) · 5135

DOI: 10.3390/molecules29215135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 30.10.2024. Verfasst von Symbat Zhumakova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 05001…. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Inflammation, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Committee of Science of the Ministry of Science and High Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synthesized compound, 1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (EPPP), and its 1:1 complex with β-cyclodextrin (EPPPβCD) have been characterized for the first time through a comprehensive suite of analytical methods. This study explores the therapeutic potential of EPPPβCD in modulating immune responses and accelerating the resolution of septic inflammation induced by chromium and vanadium ions in outbred male rats. The research highlights the significant impact of EPPPβCD on the dynamics of regulatory T lymphocytes (Tregs), notably causing a reduction in the CD4+CD25+ fractions at the onset of inflammation. This effect is attributed to the inhibition of Treg proliferation, which is crucial in hastening the resolution of inflammation. These findings underscore the potential of EPPPβCD as a promising therapeutic agent in controlling and mitigating inflammation mediated by heavy metal exposure, thereby offering a new avenue for the development of anti-inflammatory treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-CyclodextrinsInflammationT-Lymphocytes, RegulatoryAnimalsRatsMalePropionatesAnti-Inflammatory AgentsPiperidinesCell Proliferation

Stichwörter der Autor:innen

1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (EPPP)ammonium vanadate (NH4VO3)aseptic inflammationcomplex EPPP with β-cyclodextrin (EPPPβCD)heavy metal technology-related exposurepotassium bichromate (K2Cr2O7)supracomplex

Substanzen

beta-CyclodextrinsPropionatesAnti-Inflammatory AgentsPiperidinesbetadex

Autor:innen und Institutionen

  • Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan.
  • School of Chemical Engineering, Kazakh-British Technical University, 59 Tole bi St., Almaty 050000, Kazakhstan.
  • Department of Pathological Physiology, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan.
  • Health Futures Institute, Murdoch University, 90 South St., Perth, WA 6150, Australia.
  • Laboratory of Engineering Profile of NMR Spectroscopy, Sh. Ualikhanov Kokshetau State University, 76 Abai St., Kokshetau 020000, Kazakhstan.
  • Centre for Applied Research, Innovation and Entrepreneurship, Lethbridge College, 3000 College Drive South, Lethbridge, AB T1K 1L6, Canada.

ORCID-Profile: Symbat Zhumakova, Tolganay Zharkynbek, Tulegen Seilkhanov, Valery Dembitsky, Ulan Kemelbekov, Gulgul Kairanbayeva, Valentina Yu

Förderung

  • Ministry of Science and Higher Education of the Republic of Kazakhstan
  • Committee of Science of the Ministry of Science and High Education of the Republic of Kazakhstan

Zitieren

APA

Zhumakova, S., Tokusheva, A., Zharkynbek, T., Balabekova, M., Koks, S., Seilkhanov, T., Dembitsky, V., Zazybin, A., Aydemir, M., Kemelbekov, U., Kairanbayeva, G., & Yu, V. (2024). Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent. Molecules, 29(21), 5135. https://doi.org/10.3390/molecules29215135

Vancouver

Zhumakova S, Tokusheva A, Zharkynbek T, Balabekova M, Koks S, Seilkhanov T, et al. Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent. Molecules. 2024;29(21):5135. doi:10.3390/molecules29215135

BibTeX
@article{Zhumakova2024,
  author = {Zhumakova, Symbat and Tokusheva, Aliya and Zharkynbek, Tolganay and Balabekova, Marina and Koks, Sulev and Seilkhanov, Tulegen and Dembitsky, Valery and Zazybin, Alexey and Aydemir, Murat and Kemelbekov, Ulan and Kairanbayeva, Gulgul and Yu, Valentina},
  title = {Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {21},
  pages = {5135},
  doi = {10.3390/molecules29215135}
}
Kostenlos starten →